129 related articles for article (PubMed ID: 2829433)
21. Induction of EBV DNA demethylation and of EBV-specific transcription in Daudi cells treated with TPA and n-butyrate.
Collandre H; Guetard D; Montagnier L
Intervirology; 1984; 22(4):201-10. PubMed ID: 6096292
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus induces fragmentation of chromosomal DNA during lytic infection.
Kawanishi M
J Virol; 1993 Dec; 67(12):7654-8. PubMed ID: 8230485
[TBL] [Abstract][Full Text] [Related]
24. The biological activity of hydrogen peroxide. III. Induction of Epstein-Barr virus via indirect action, as compared with TPA and teleocidin.
Oya Y; Tonomura A; Yamamoto K
Int J Cancer; 1987 Jul; 40(1):69-73. PubMed ID: 3036721
[TBL] [Abstract][Full Text] [Related]
25. The transforming prototype of Epstein-Barr virus (B95-8) is also a lytic virus.
Glaser R; Tarr KL; Dangel AW
Int J Cancer; 1989 Jul; 44(1):95-100. PubMed ID: 2545637
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells.
Boos H; Berger R; Kuklik-Roos C; Iftner T; Mueller-Lantzsch N
Virology; 1987 Jul; 159(1):161-5. PubMed ID: 3037776
[TBL] [Abstract][Full Text] [Related]
27. Phosphonoacetic acid-resistant RNA of Epstein-Barr virus in productively infected cells.
Shin S; Donovan J; Nonoyama M
Virology; 1983 Jan; 124(1):196-200. PubMed ID: 6130649
[TBL] [Abstract][Full Text] [Related]
28. Induction of Epstein-Barr virus by an new tumor promoter, teleocidin, compared to induction by TPA.
Yamamoto H; Katsuki T; Hinuma Y; Hoshino H; Miwa M; Fujiki H; Sugimura T
Int J Cancer; 1981 Aug; 28(2):125-9. PubMed ID: 6274809
[TBL] [Abstract][Full Text] [Related]
29. Unchanged expression of Epstein-Barr virus-determined nuclear antigen-1 in productive virus cycle.
Nováková Z; Krchnák V; Roubal J
Acta Virol; 1988 Jul; 32(4):349-52. PubMed ID: 2903640
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of kampo medicine on Epstein-Barr virus antigen induction by tumor promoter.
Furukawa M; Sakashita H; Kamide M; Umeda R
Auris Nasus Larynx; 1990; 17(1):49-54. PubMed ID: 2167654
[TBL] [Abstract][Full Text] [Related]
31. Identification of Epstein-Barr virus genes expressed during the early phase of virus replication and during lymphocyte immortalization.
Sample J; Tanaka A; Lancz G; Nonoyama M
Virology; 1984 Nov; 139(1):1-10. PubMed ID: 6093376
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of replication of Epstein-Barr virus DNA in human lymphoblastoid cell lines by N-methyl-N'-nitro-N-nitrosoguanidine.
Lin JC; Smith MC; Pagano JS
Carcinogenesis; 1983; 4(2):185-8. PubMed ID: 6297823
[TBL] [Abstract][Full Text] [Related]
33. 12-O-tetradecanoylphorbol-13-acetate induces Epstein-Barr virus reactivation via NF-kappaB and AP-1 as regulated by protein kinase C and mitogen-activated protein kinase.
Gao X; Ikuta K; Tajima M; Sairenji T
Virology; 2001 Jul; 286(1):91-9. PubMed ID: 11448162
[TBL] [Abstract][Full Text] [Related]
34. Effect of indomethacin on Epstein-Barr virus early antigen induction.
Daniel LW; Bauer G; zur Hausen H
Cancer Res; 1984 Mar; 44(3):981-3. PubMed ID: 6318991
[TBL] [Abstract][Full Text] [Related]
35. Novel 12-O-tetradecanoylphorbol-13-acetate-responsive elements in the upstream sequence of the MS gene promoter of Epstein-Barr virus.
Liu QY; Summers WC
J Virol; 1989 Dec; 63(12):5062-8. PubMed ID: 2555542
[TBL] [Abstract][Full Text] [Related]
36. Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines.
Boguszaková L; Hirsch I; Brichácek B; Vonka V
J Gen Virol; 1983 Apr; 64 (Pt 4)():887-94. PubMed ID: 6300308
[TBL] [Abstract][Full Text] [Related]
37. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
[TBL] [Abstract][Full Text] [Related]
38. Cellular and Epstein-Barr virus specific DNA polymerases in virus-producing Burkitt's lymphoma cell lines.
Allaudeen HS; Rani G
Nucleic Acids Res; 1982 Apr; 10(7):2453-65. PubMed ID: 6283481
[TBL] [Abstract][Full Text] [Related]
39. Major EB virus-specific cytoplasmic transcripts in a cellular clone of the HR-1 Burkitt lymphoma line during latency and after induction of viral replicative cycle by phorbol esters.
Weigel R; Miller G
Virology; 1983 Mar; 125(2):287-98. PubMed ID: 6301144
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced induction in Epstein-Barr virus early antigen in Raji cells.
Okamoto H; Yoshida D; Mizusaki S
Cancer Lett; 1983 May; 19(1):47-53. PubMed ID: 6850568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
